No abstract available
Keywords:
4203 Health Services and Systems
,42 Health Sciences
,Diabetes
,Clinical Research
,Clinical Trials and Supportive Activities
,Cardiovascular
,Prevention
,Heart Disease
,Cardiovascular
,Diabetes Mellitus, Type 2
,Heart Failure
,Humans
,Hypoglycemic Agents
,Meta-Analysis as Topic
,Pioglitazone
,Practice Guidelines as Topic
,Randomized Controlled Trials as Topic
,Risk Factors
,Rosiglitazone
,Thiazolidinediones
